Abstract
Haemagglutinin and neuraminidase have clearly been shown to be responsible for the stimulation of immunity against influenza.
In the approach described, these two immunogens are selectively solubilized, leaving an intact subviral particle which contains lipid and non-protective components. The methods used can readily be adapted to large scale production.
The immunogenicity of such antigen-preparation was studied in different animal species. Antibodies against haemagglutinin and neuraminidase were measured in mice, hamsters, guinea-pigs and rabbits. In addition, mice-protection experiments were performed.
The immune response of volunteers to this type of subunit vaccine has also been evaluated (Kunz and Hofmann, 1975). Results of a first field trial indicate that the solubilization procedure did not alter the immunogenic properties of the two antigens.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bachmayer H. Selective solubilization of hemagglutinin and neuraminidase from influenza viruses. Intervirology. 1975;5(5):260–272. doi: 10.1159/000149923. [DOI] [PubMed] [Google Scholar]
- Dowdle W. R., Coleman M. T., Mostow S. R., Kaye H. S., Schoenbaum S. C. Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgrad Med J. 1973 Mar;49(569):159–163. doi: 10.1136/pgmj.49.569.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krag P., Bentzon M. W. The international reference preparation of influenza virus haemagglutinin (type A). Bull World Health Organ. 1971;45(4):473–486. [PMC free article] [PubMed] [Google Scholar]
- Schild G. C., Wood J. M., Newman R. W. A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines. Bull World Health Organ. 1975;52(2):223–231. [PMC free article] [PubMed] [Google Scholar]